CSAM Health Group AS
CSAMF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $424,959 | $410,458 | $366,669 | $329,303 |
| % Growth | 3.5% | 11.9% | 11.3% | – |
| Cost of Goods Sold | $31,032 | $32,010 | $33,380 | $35,368 |
| Gross Profit | $393,927 | $378,448 | $333,289 | $293,935 |
| % Margin | 92.7% | 92.2% | 90.9% | 89.3% |
| R&D Expenses | $0 | $468 | $0 | $0 |
| G&A Expenses | $0 | $19,707 | $22,969 | $14,677 |
| SG&A Expenses | $0 | $21,283 | $25,492 | $17,604 |
| Sales & Mktg Exp. | $0 | $1,576 | $2,523 | $2,927 |
| Other Operating Expenses | $397,064 | $228,011 | $398,246 | $318,153 |
| Operating Expenses | $397,064 | $249,762 | $423,738 | $335,757 |
| Operating Income | -$3,137 | $128,686 | -$90,449 | -$41,822 |
| % Margin | -0.7% | 31.4% | -24.7% | -12.7% |
| Other Income/Exp. Net | -$56,942 | -$25,317 | -$45,883 | -$47,288 |
| Pre-Tax Income | -$60,079 | $103,369 | -$136,332 | -$89,110 |
| Tax Expense | -$789 | -$8,353 | -$4,733 | -$2,547 |
| Net Income | -$59,290 | $104,350 | -$131,598 | -$86,563 |
| % Margin | -14% | 25.4% | -35.9% | -26.3% |
| EPS | -2.94 | 5.11 | -6.29 | -4.13 |
| % Growth | -157.5% | 181.2% | -52.3% | – |
| EPS Diluted | -2.94 | 5.11 | -6.29 | -4.13 |
| Weighted Avg Shares Out | 20,180 | 20,423 | 20,936 | 20,967 |
| Weighted Avg Shares Out Dil | 20,180 | 20,423 | 20,936 | 20,967 |
| Supplemental Information | – | – | – | – |
| Interest Income | $3,213 | $24,672 | $1,968 | -$20,604 |
| Interest Expense | $60,154 | $49,990 | $37,198 | $26,697 |
| Depreciation & Amortization | $56,066 | -$65,425 | $88,866 | $83,653 |
| EBITDA | $56,149 | $224,711 | -$10,268 | $21,240 |
| % Margin | 13.2% | 54.7% | -2.8% | 6.4% |